Valuation: Pfizer Inc

Market Cap 16TCr 14TCr 13TCr 12TCr 22TCr 15,30800Cr 22TCr 1,51500Cr 59TCr 7,69000Cr 60TCr 59TCr 25,43500Cr P/E 2026 *
17.6x
P/E 2027 * 13.8x
Enterprise Value 21TCr 18TCr 17TCr 15TCr 29TCr 19,85100Cr 29TCr 1,96500Cr 77TCr 9,97200Cr 78TCr 76TCr 32,98300Cr EV / Sales 2026 *
3.33x
EV / Sales 2027 * 3.39x
Free-Float
59.05%
Yield 2026 *
6.13%
Yield 2027 * 6.18%
Manager TitleAgeSince
Chief Executive Officer 64 01/01/2019
Director of Finance/CFO 55 16/08/2026
Compliance Officer 65 01/12/2013
Director TitleAgeSince
Director/Board Member 68 01/09/2007
Director/Board Member 62 27/09/2013
Chairman 64 01/01/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.88%+6.38%+76.86%+128.23% 1,11900Cr
+1.07%+3.80%+51.03%+61.48% 65TCr
+1.20%+6.21%+26.47%+76.45% 47TCr
+1.02%+5.77%+43.09%+47.70% 37TCr
+0.85%+4.07%+23.88%+41.58% 30TCr
+1.26%+6.81%+1.59%+14.67% 26TCr
+1.88%+5.81%+48.54%+68.52% 24TCr
+1.59%+2.09%-15.52%-52.29% 21TCr
+1.87%+5.61%+25.81%+92.42% 18TCr
Average +1.29%+4.97%+31.31%+53.20% 42.22TCr
Weighted average by Cap. +1.14%+5.09%+44.31%+72.55%

Financials

2026 *2027 *
Net sales 6.22TCr 5.33TCr 4.99TCr 4.57TCr 8.57TCr 5,95500Cr 8.68TCr 59TCr 23TCr 2,99100Cr 23TCr 23TCr 9,89400Cr 5.98TCr 5.13TCr 4.8TCr 4.39TCr 8.24TCr 5,72500Cr 8.35TCr 57TCr 22TCr 2,87600Cr 22TCr 22TCr 9,51300Cr
Net income 890.05Cr 762.41Cr 713.37Cr 653.01Cr 1.23TCr 85TCr 1.24TCr 8.43TCr 3.29TCr 43TCr 3.34TCr 3.27TCr 1,41500Cr 1.11TCr 949.13Cr 888.08Cr 812.93Cr 1.53TCr 1,06000Cr 1.55TCr 10TCr 4.09TCr 53TCr 4.16TCr 4.07TCr 1,76100Cr
Net Debt 4.75TCr 4.07TCr 3.81TCr 3.48TCr 6.54TCr 4,54300Cr 6.62TCr 45TCr 18TCr 2,28200Cr 18TCr 17TCr 7,54900Cr 4.29TCr 3.67TCr 3.44TCr 3.15TCr 5.9TCr 4,10300Cr 5.98TCr 41TCr 16TCr 2,06100Cr 16TCr 16TCr 6,81700Cr
Logo Pfizer Inc
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (42.9%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (28%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (26.9%); - other (2.2%). The United States accounts for 59.2% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-